UNI-EN 3:Q4 2019 Individual Financial report of Sopharma AD
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 3 | / | 2020 | |||||||
| Date of issue: | 2020-01-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Q4 2019 Individual Financial report of Sopharma AD | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Q4 2019 Individual Financial report of Sopharma AD: Individual financial report according to IFRS as at 31 December 2019 Notes to the individual financial report as at 31 December 2019 Management report as at 31 December 2019 Insider information as at 31 December 2019 Additional information as at 31 December 2019 Individual financial report according to BFSC standards as at 31 December 2019 Information according to Annex 9 of Ordinance 2 as at 31 December 2019 Declaration by the responsible directors as at 31 December 2019 | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Financial_statements_Q4_2019_EN.zip 3JR_Financial_statements_Q4_2019_EN.zip | Q4 2019 Individual Financial report of Sopharma AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2020-01-30 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 8.3 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
